drugset / Trial / NCT02343393

Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study

NCT02343393

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a single-blind, randomised, clinical trial assessing the efficacy of Hydralazine and Isosorbidedinitrate combination (oral agents) in HF patients with renal dysfunction.

Timeline

Start
2015-01
Primary completion
2015-12
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydralazine Small molecule 120 mg Oral
Subject Isosorbide Dinitrate Other / unclassified 60 mg Oral

Indications